QRSL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.10622663543836E-15 |
Normal-vs-Stage2 |
1.07000000004742E-06 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
5.38991073995021E-12 |
Stage1-vs-Stage2 |
6.722200E-01 |
Stage1-vs-Stage3 |
3.703400E-03 |
Stage1-vs-Stage4 |
1.347600E-01 |
Stage2-vs-Stage3 |
3.860400E-02 |
Stage2-vs-Stage4 |
1.630430E-01 |
Stage3-vs-Stage4 |
5.801400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
4.63639999948029E-07 |
Normal-vs-Asian |
1.185440E-01 |
Caucasian-vs-AfricanAmerican |
2.088000E-01 |
Caucasian-vs-Asian |
8.516300E-02 |
AfricanAmerican-vs-Asian |
3.214000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62458935193399E-12 |
Normal-vs-Female |
1.65401026208656E-12 |
Male-vs-Female |
1.102950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.03299999057549E-09 |
Normal-vs-Age(41-60Yrs) |
1.626032641866E-12 |
Normal-vs-Age(61-80Yrs) |
6.66133814775094E-16 |
Normal-vs-Age(81-100Yrs) |
3.39990000042256E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.831400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.156800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.006800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.251600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.339400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.675400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.421980E-02 |
Normal-vs-Grade 2 |
4.44089209850063E-15 |
Normal-vs-Grade 3 |
9.99200722162641E-16 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.853630E-01 |
Grade 1-vs-Grade 3 |
1.411390E-01 |
Grade 1-vs-Grade 4 |
7.522400E-03 |
Grade 2-vs-Grade 3 |
3.624800E-01 |
Grade 2-vs-Grade 4 |
1.178850E-03 |
Grade 3-vs-Grade 4 |
2.210100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.1209700662439E-12 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
1.756070E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.74749104076E-12 |
Normal-vs-N1 |
1.79019999935193E-08 |
N0-vs-N1 |
9.714300E-02 |
|
|